What question did this study set out to answer?

This research examines the effectiveness of the neutrophil-monocyte-to-lymphocyte ratio (NMLR) in predicting outcomes for acute ischemic stroke (AIS) patients.

April 24, 2026Brain and Behavior0 citationsOpen Access

View Full Paper

Neutrophil‐Monocyte‐to‐Lymphocyte Ratio as a Valid Prognostic Tool for Acute Ischemic Stroke With Performance Comparable to Neutrophil‐to‐Lymphocyte Ratio

YZY Y ZhaoCapital Medical University LYLi YiCapital Medical University SSShen ShenCapital Medical University

Key Points

This research examines the effectiveness of the neutrophil-monocyte-to-lymphocyte ratio (NMLR) in predicting outcomes for acute ischemic stroke (AIS) patients.
Prospective study design
Assessment of NMLR and its comparison with neutrophil-to-lymphocyte ratio (NLR)
Evaluation of functional outcomes at 90 days post-AIS
NMLR reliably predicts poor 90-day outcomes in AIS patients
Performance of NMLR is comparable to that of NLR

Abstract

This is the first prospective study to assess the predictive value of the NMLR for 3-month functional outcomes in patients with AIS and systematically compare NMLR with NLR. NMLR can predict poor 90-day outcomes in patients with AIS independently. NMLR is a valid prognostic tool for AIS with performance comparable to NLR.

问 AI

Bookmark

View Full Paper

问 AI

Bookmark

View Full Paper

Neutrophil‐Monocyte‐to‐Lymphocyte Ratio as a Valid Prognostic Tool for Acute Ischemic Stroke With Performance Comparable to Neutrophil‐to‐Lymphocyte Ratio

Key Points

Abstract

Cite This Study

Also Consider

Also Consider